Overview

Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)

Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This investigational study will investigate two different volume replacement regimes in patients suffering from compromised renal function.
Phase:
Phase 4
Details
Lead Sponsor:
B. Braun Melsungen AG
Treatments:
Pharmaceutical Solutions